Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $20.0200 (-0.25%) ($19.7100 - $20.6000) on Wed. Jan. 25, 2006. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.49% (three month average) | RSI | 63 | Latest Price | $20.0200(-0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) QQQ(7%) EEM(6%) IWM(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.245% in a week (0% probabilities). SHY(-4%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.245% (StdDev 6.49%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $20.22(-0.99%) | 10 Day Moving Average | $20.18(-0.79%) | 20 Day Moving Average | $19.1(4.82%) | To recent high | -10.7% | To recent low | 78% | Market Cap | $3.532b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |